首页 > 最新文献

Current neurovascular research最新文献

英文 中文
Nomogram to Predict 90-Day All-Cause Mortality in Acute Ischemic Stroke Patients after Endovascular Thrombectomy 预测急性缺血性脑卒中患者血管内血栓切除术后 90 天全因死亡率的提名图
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-04-27 DOI: 10.2174/0115672026311086240415050048
Shiya Zhang, Shuai Yu, Xiaocui Wang, Zhiliang Guo, Jie Hou, Huaishun Wang, Zhichao Huang, Guodong Xiao, Shoujiang You
Objective: Although Endovascular Thrombectomy (EVT) significantly improves the prognosis of Acute Ischemic Stroke (AIS) patients with large vessel occlusion, the mortality rate remains higher. This study aimed to construct and validate a nomogram for predicting 90-day all-cause mortality in AIS patients with large vessel occlusion and who have undergone EVT. Methods: AIS patients with large vessel occlusion in the anterior circulation who underwent EVT from May 2017 to December 2022 were included. 430 patients were randomly split into a training group (N=302) and a test group (N=128) for the construction and validation of our nomogram. In the training group, multivariate logistic regression analysis was performed to determine the predictors of 90-day all-cause mortality. The C-index, calibration plots, and decision curve analysis were applied to evaluate the nomogram performance. Results: Multivariate logistic regression analysis revealed neurological deterioration during hospitalization, age, baseline National Institutes of Health Stroke Scale (NIHSS) score, occlusive vessel location, malignant brain edema, and Neutrophil-to-lymphocyte Ratio (NLR) as the independent predictors of 90-day all-cause mortality (all p ≤ 0.039). The C-index of the training and test groups was 0.891 (95%CI 0.848-0.934) and 0.916 (95% CI: 0.865-0.937), respectively, showing the nomogram to be well distinguished. The Hosmer-Lemeshow goodness-of-fit test revealed the p-values for both the internal and external verification datasets to be greater than 0.5. Conclusion: Our nomogram has incorporated relevant clinical and imaging features, including neurological deterioration, age, baseline NIHSS score, occlusive vessel location, malignant brain edema, and NLR ratio, to provide an accurate and reliable prediction of 90-day all-cause mortality in AIS patients undergoing EVT.
目的:虽然血管内血栓切除术(EVT)能明显改善大血管闭塞的急性缺血性卒中(AIS)患者的预后,但死亡率仍然较高。本研究旨在构建并验证一个提名图,用于预测接受过 EVT 的大血管闭塞急性缺血性卒中 (AIS) 患者的 90 天全因死亡率。方法:纳入2017年5月至2022年12月期间接受EVT的前循环大血管闭塞的AIS患者。430 名患者被随机分为训练组(N=302)和测试组(N=128),用于构建和验证我们的提名图。在训练组中,我们进行了多变量逻辑回归分析,以确定 90 天全因死亡率的预测因素。应用 C 指数、校准图和决策曲线分析来评估提名图的性能。结果多变量逻辑回归分析显示,住院期间神经功能恶化、年龄、美国国立卫生研究院卒中量表(NIHSS)基线评分、闭塞血管位置、恶性脑水肿和中性粒细胞与淋巴细胞比值(NLR)是 90 天全因死亡率的独立预测因素(所有 p 均小于 0.039)。训练组和测试组的 C 指数分别为 0.891(95%CI 0.848-0.934)和 0.916(95%CI:0.865-0.937),表明提名图具有良好的区分度。Hosmer-Lemeshow 拟合优度检验显示,内部和外部验证数据集的 p 值均大于 0.5。结论我们的提名图结合了相关的临床和影像学特征,包括神经功能恶化、年龄、基线 NIHSS 评分、闭塞血管位置、恶性脑水肿和 NLR 比值,能准确可靠地预测接受 EVT 的 AIS 患者的 90 天全因死亡率。
{"title":"Nomogram to Predict 90-Day All-Cause Mortality in Acute Ischemic Stroke Patients after Endovascular Thrombectomy","authors":"Shiya Zhang, Shuai Yu, Xiaocui Wang, Zhiliang Guo, Jie Hou, Huaishun Wang, Zhichao Huang, Guodong Xiao, Shoujiang You","doi":"10.2174/0115672026311086240415050048","DOIUrl":"https://doi.org/10.2174/0115672026311086240415050048","url":null,"abstract":"Objective: Although Endovascular Thrombectomy (EVT) significantly improves the prognosis of Acute Ischemic Stroke (AIS) patients with large vessel occlusion, the mortality rate remains higher. This study aimed to construct and validate a nomogram for predicting 90-day all-cause mortality in AIS patients with large vessel occlusion and who have undergone EVT. Methods: AIS patients with large vessel occlusion in the anterior circulation who underwent EVT from May 2017 to December 2022 were included. 430 patients were randomly split into a training group (N=302) and a test group (N=128) for the construction and validation of our nomogram. In the training group, multivariate logistic regression analysis was performed to determine the predictors of 90-day all-cause mortality. The C-index, calibration plots, and decision curve analysis were applied to evaluate the nomogram performance. Results: Multivariate logistic regression analysis revealed neurological deterioration during hospitalization, age, baseline National Institutes of Health Stroke Scale (NIHSS) score, occlusive vessel location, malignant brain edema, and Neutrophil-to-lymphocyte Ratio (NLR) as the independent predictors of 90-day all-cause mortality (all p ≤ 0.039). The C-index of the training and test groups was 0.891 (95%CI 0.848-0.934) and 0.916 (95% CI: 0.865-0.937), respectively, showing the nomogram to be well distinguished. The Hosmer-Lemeshow goodness-of-fit test revealed the p-values for both the internal and external verification datasets to be greater than 0.5. Conclusion: Our nomogram has incorporated relevant clinical and imaging features, including neurological deterioration, age, baseline NIHSS score, occlusive vessel location, malignant brain edema, and NLR ratio, to provide an accurate and reliable prediction of 90-day all-cause mortality in AIS patients undergoing EVT.","PeriodicalId":10879,"journal":{"name":"Current neurovascular research","volume":"74 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140809903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electroacupuncture Inhibits Neural Ferroptosis in Rat Model of Traumatic Brain Injury via Activating System Xc−/GSH/GPX4 Axis 电针通过激活 Xc-/GSH/GPX4 系统轴抑制创伤性脑损伤大鼠模型的神经铁凋亡
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-04-17 DOI: 10.2174/0115672026297775240405073502
Na Li, Ruihui Wang, Xia Ai, Jie Guo, Yuwang Bai, Xinrong Guo, Rongchao Zhang, Xu Du, Jingxuan Chen, Hua Li
Background: Ferroptosis is an iron-dependent regulating programmed cell death discovered recently that has been receiving much attention in traumatic brain injury (TBI). xCT, a major functional subunit of Cystine/glutamic acid reverse transporter (System Xc−), promotes cystine intake and glutathione biosynthesis, thereby protecting against oxidative stress and ferroptosis. Objective: The intention of this research was to verify the hypothesis that electroacupuncture (EA) exerted an anti-ferroptosis effect via an increase in the expression of xCT and activation of the System Xc−/GSH/GPX4 axis in cortical neurons of TBI rats. Methods: After the TBI rat model was prepared, animals received EA treatment at GV20, GV26, ST36 and PC6, for 15min. The xCT inhibitor Sulfasalazine (SSZ) was administered 2h prior to model being prepared. The degree of neurological impairment was evaluated by means of TUNEL staining and the modified neurological severity score (mNSS). Specific indicators of ferroptosis (Ultrastructure of mitochondria, Iron and ROS) were detected by transmission electron microscopy (TEM), Prussian blue staining (Perls stain) and flow cytometry (FCM), respectively. GSH synthesis and metabolism-related factors in the content of the cerebral cortex were detected by an assay kit. Real-time quantitative PCR (RT-QPCR), Western blot (WB), and immunofluorescence (IF) were used for detecting the expression of System Xc−/GSH/GPX4 axisrelated proteins in injured cerebral cortex tissues. Results: EA successfully relieved nerve damage within 7 days after TBI, significantly inhibited neuronal ferroptosis, upregulated the expression of xCT and System Xc−/GSH/GPX4 axis forward protein and promoted glutathione (GSH) synthesis and metabolism in the injured area of the cerebral cortex. However, aggravation of nerve damage and increased ferroptosis effect were found in TBI rats injected with xCT inhibitors. Conclusions: EA inhibits neuronal ferroptosis by up-regulated xCT expression and by activating System Xc−/GSH/GPX4 axis after TBI, confirming the relevant theories regarding the EA effect in treating TBI and providing theoretical support for clinical practice. conclusion: EA Inhibits Neuronal Ferroptosis by up-regulated xCT expression and by Activating System Xc−/GSH/GPX4 axis after TBI, confirming the relevant theories regarding the effect of EA treatment on TBI and guiding clinical practice.
背景:xCT是胱氨酸/谷氨酸反向转运体(Xc-系统)的一个主要功能亚基,它能促进胱氨酸摄入和谷胱甘肽的生物合成,从而保护细胞免受氧化应激和铁变态反应的影响。研究目的本研究旨在验证电针(EA)通过增加 TBI 大鼠皮质神经元中 xCT 的表达和激活 System Xc-/GSH/GPX4 轴发挥抗铁蛋白沉积作用的假设。研究方法制备 TBI 大鼠模型后,在 GV20、GV26、ST36 和 PC6 处对动物进行 15 分钟的 EA 处理。在制备模型前 2 小时,给大鼠注射 xCT 抑制剂磺胺沙拉嗪(SSZ)。神经损伤程度通过 TUNEL 染色和改良神经严重程度评分(mNSS)进行评估。透射电子显微镜(TEM)、普鲁士蓝染色法(Perls 染色法)和流式细胞术(FCM)分别检测铁中毒的特定指标(线粒体超微结构、铁和 ROS)。检测试剂盒检测了大脑皮层内容物中的 GSH 合成和代谢相关因子。采用实时定量 PCR(RT-QPCR)、Western 印迹(WB)和免疫荧光(IF)检测损伤大脑皮层组织中 System Xc-/GSH/GPX4 轴相关蛋白的表达。结果EA成功缓解了创伤性脑损伤后7天内的神经损伤,显著抑制了神经元的铁突变,上调了xCT和System Xc-/GSH/GPX4轴前导蛋白的表达,促进了大脑皮层损伤区谷胱甘肽(GSH)的合成和代谢。然而,注射了 xCT 抑制剂的创伤性脑损伤大鼠神经损伤加重,铁蛋白沉积效应增强。结论EA在TBI后通过上调xCT表达和激活System Xc-/GSH/GPX4轴抑制神经元铁突变,证实了EA治疗TBI效果的相关理论,为临床实践提供了理论支持:EA在TBI后通过上调xCT表达和激活系统Xc-/GSH/GPX4轴抑制神经元铁凋亡,证实了EA治疗TBI效果的相关理论,为临床实践提供了指导。
{"title":"Electroacupuncture Inhibits Neural Ferroptosis in Rat Model of Traumatic Brain Injury via Activating System Xc−/GSH/GPX4 Axis","authors":"Na Li, Ruihui Wang, Xia Ai, Jie Guo, Yuwang Bai, Xinrong Guo, Rongchao Zhang, Xu Du, Jingxuan Chen, Hua Li","doi":"10.2174/0115672026297775240405073502","DOIUrl":"https://doi.org/10.2174/0115672026297775240405073502","url":null,"abstract":"Background: Ferroptosis is an iron-dependent regulating programmed cell death discovered recently that has been receiving much attention in traumatic brain injury (TBI). xCT, a major functional subunit of Cystine/glutamic acid reverse transporter (System Xc−), promotes cystine intake and glutathione biosynthesis, thereby protecting against oxidative stress and ferroptosis. Objective: The intention of this research was to verify the hypothesis that electroacupuncture (EA) exerted an anti-ferroptosis effect via an increase in the expression of xCT and activation of the System Xc−/GSH/GPX4 axis in cortical neurons of TBI rats. Methods: After the TBI rat model was prepared, animals received EA treatment at GV20, GV26, ST36 and PC6, for 15min. The xCT inhibitor Sulfasalazine (SSZ) was administered 2h prior to model being prepared. The degree of neurological impairment was evaluated by means of TUNEL staining and the modified neurological severity score (mNSS). Specific indicators of ferroptosis (Ultrastructure of mitochondria, Iron and ROS) were detected by transmission electron microscopy (TEM), Prussian blue staining (Perls stain) and flow cytometry (FCM), respectively. GSH synthesis and metabolism-related factors in the content of the cerebral cortex were detected by an assay kit. Real-time quantitative PCR (RT-QPCR), Western blot (WB), and immunofluorescence (IF) were used for detecting the expression of System Xc−/GSH/GPX4 axisrelated proteins in injured cerebral cortex tissues. Results: EA successfully relieved nerve damage within 7 days after TBI, significantly inhibited neuronal ferroptosis, upregulated the expression of xCT and System Xc−/GSH/GPX4 axis forward protein and promoted glutathione (GSH) synthesis and metabolism in the injured area of the cerebral cortex. However, aggravation of nerve damage and increased ferroptosis effect were found in TBI rats injected with xCT inhibitors. Conclusions: EA inhibits neuronal ferroptosis by up-regulated xCT expression and by activating System Xc−/GSH/GPX4 axis after TBI, confirming the relevant theories regarding the EA effect in treating TBI and providing theoretical support for clinical practice. conclusion: EA Inhibits Neuronal Ferroptosis by up-regulated xCT expression and by Activating System Xc−/GSH/GPX4 axis after TBI, confirming the relevant theories regarding the effect of EA treatment on TBI and guiding clinical practice.","PeriodicalId":10879,"journal":{"name":"Current neurovascular research","volume":"39 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140617846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extract of Gualou-Xiebai Herb Pair Improves Lipid Metabolism Disorders by Enhancing the Reverse Cholesterol Transport in Atherosclerosis Mice 瓜蒌仙草对提取物通过增强动脉粥样硬化小鼠的胆固醇逆向转运改善脂质代谢紊乱
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-04-17 DOI: 10.2174/0115672026308438240405055719
Yarong Liu, Tian Wang, Lidan Ding, Zhenglong Li, Yexiang Zhang, Min Dai, Hongfei Wu
Background: Gualou is derived from the fruit of Trichosanthes kirilowii Maxim, while Xiebai from the bulbs of Allium macrostemon Bunge. Gualou and Xiebai herb pair (2:1) is widely used in clinical practice to treat atherosclerotic cardiovascular diseases. However, the mechanism underlying its potential activity on atherosclerosis (AS) has not been fully elucidated. Methods: The extract of Gualou-Xiebai herb pair (GXE) was prepared from Gualou (80 g) and Xiebai (40 g) by continuous refluxing with 50% ethanol for 2 h at 80°C. In vivo, ApoE-/- mice were fed a high-fat diet (HFD) for 10 weeks to induce an AS model, and then the mice were treated with GXE (3, 6, 12 g/kg) or atorvastatin (10 mg/kg) via oral gavage. Besides, RAW264.7 macrophages were stimulated by ox-LDL to establish a foam cell model in vitro. Results: GXE suppressed plaque formation, regulated plasma lipids, and promoted liver lipid clearance in AS mice. In addition, 0.5, 1, and 2 mg/mL GXE significantly reduced the TC and FC levels in ox-LDL (50 μg/mL)-stimulated foam cells. GXE increased cholesterol efflux from the foam cells to ApoA-1 and HDL, and enhanced the protein expressions of ABCA1, ABCG1, and SR-BI, which were reversed by the PPARγ inhibitor. Meanwhile, GXE increased the LCAT levels, decreased the lipid levels and increased the TBA levels in the liver of AS mice. Molecular docking indicated that some compounds in GXE showed favorable binding energy with PPARγ, LCAT and CYP7A1 proteins, especially apigenin-7-O-β-D-glucoside and quercetin. Conclusion: In summary, our results suggested that GXE improved lipid metabolism disorders by enhancing RCT, providing a scientific basis for the clinical use of GXE in AS treatment.
背景介绍瓜蒌提取自Trichosanthes kirilowii Maxim的果实,而解百则提取自Allium macrostemon Bunge的鳞茎。临床上广泛使用瓜蒌和仙鹤草配伍(2:1)来治疗动脉粥样硬化性心血管疾病。然而,其对动脉粥样硬化(AS)潜在活性的机制尚未完全阐明。研究方法用 50%的乙醇在 80°C 下连续回流 2 小时,制备瓜蒌-解百草提取物(GXE)。在体内,用高脂饮食(HFD)诱导载脂蛋白E-/-小鼠10周,然后通过口服GXE(3、6、12克/千克)或阿托伐他汀(10毫克/千克)对小鼠进行治疗。此外,在体外用 ox-LDL 刺激 RAW264.7 巨噬细胞以建立泡沫细胞模型。结果显示GXE抑制了AS小鼠斑块的形成,调节了血浆脂质,并促进了肝脏脂质的清除。此外,0.5、1 和 2 毫克/毫升的 GXE 能显著降低氧化-LDL(50 微克/毫升)刺激的泡沫细胞中的 TC 和 FC 水平。GXE 增加了泡沫细胞向载脂蛋白 ApoA-1 和 HDL 的胆固醇外流,并提高了 ABCA1、ABCG1 和 SR-BI 的蛋白表达,而 PPARγ 抑制剂可逆转这些变化。同时,GXE能提高AS小鼠肝脏中的LCAT水平,降低血脂水平,提高TBA水平。分子对接表明,GXE 中的一些化合物与 PPARγ、LCAT 和 CYP7A1 蛋白具有良好的结合能,尤其是芹菜素-7-O-β-D-葡萄糖苷和槲皮素。结论综上所述,我们的研究结果表明,GXE 可通过增强 RCT 改善脂质代谢紊乱,为临床上使用 GXE 治疗强直性脊柱炎提供了科学依据。
{"title":"Extract of Gualou-Xiebai Herb Pair Improves Lipid Metabolism Disorders by Enhancing the Reverse Cholesterol Transport in Atherosclerosis Mice","authors":"Yarong Liu, Tian Wang, Lidan Ding, Zhenglong Li, Yexiang Zhang, Min Dai, Hongfei Wu","doi":"10.2174/0115672026308438240405055719","DOIUrl":"https://doi.org/10.2174/0115672026308438240405055719","url":null,"abstract":"Background: Gualou is derived from the fruit of Trichosanthes kirilowii Maxim, while Xiebai from the bulbs of Allium macrostemon Bunge. Gualou and Xiebai herb pair (2:1) is widely used in clinical practice to treat atherosclerotic cardiovascular diseases. However, the mechanism underlying its potential activity on atherosclerosis (AS) has not been fully elucidated. Methods: The extract of Gualou-Xiebai herb pair (GXE) was prepared from Gualou (80 g) and Xiebai (40 g) by continuous refluxing with 50% ethanol for 2 h at 80°C. In vivo, ApoE-/- mice were fed a high-fat diet (HFD) for 10 weeks to induce an AS model, and then the mice were treated with GXE (3, 6, 12 g/kg) or atorvastatin (10 mg/kg) via oral gavage. Besides, RAW264.7 macrophages were stimulated by ox-LDL to establish a foam cell model in vitro. Results: GXE suppressed plaque formation, regulated plasma lipids, and promoted liver lipid clearance in AS mice. In addition, 0.5, 1, and 2 mg/mL GXE significantly reduced the TC and FC levels in ox-LDL (50 μg/mL)-stimulated foam cells. GXE increased cholesterol efflux from the foam cells to ApoA-1 and HDL, and enhanced the protein expressions of ABCA1, ABCG1, and SR-BI, which were reversed by the PPARγ inhibitor. Meanwhile, GXE increased the LCAT levels, decreased the lipid levels and increased the TBA levels in the liver of AS mice. Molecular docking indicated that some compounds in GXE showed favorable binding energy with PPARγ, LCAT and CYP7A1 proteins, especially apigenin-7-O-β-D-glucoside and quercetin. Conclusion: In summary, our results suggested that GXE improved lipid metabolism disorders by enhancing RCT, providing a scientific basis for the clinical use of GXE in AS treatment.","PeriodicalId":10879,"journal":{"name":"Current neurovascular research","volume":"231 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140615456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of 4 mm-sized and 3 mm-sized Stent Retrievers in Mechanical Thrombectomy for M2 Occlusion 在 M2 闭塞的机械血栓清除术中使用 4 毫米大小和 3 毫米大小支架取栓器的比较
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-04-15 DOI: 10.2174/0115672026303196240327053722
Han Gyul Lee, Ho Jun Yi, Dong-Seong Shin, Bum-Tae Kim
Introduction: A stent retriever (SR) is widely used in mechanical thrombectomy (MT) for M2 segment occlusion. However, the suitable size of SR in M2 occlusion remains unclear. Therefore, we aimed to compare 4 mm-sized SR with 3 mm-sized SR in M2 occlusion. Methods: Patients who underwent MT with SR for M2 occlusion were dichotomized into 4×20 mm SR and 3×20 mm SR groups. Then, 1:1 propensity score matching was performed. The M2 segment was divided into proximal and distal segments according to the occlusion site. Subgroup analysis was then performed for each cohort. Results: A total of 111 patients were enrolled, with 4×20 mm SR and 3×20 mm SR applied in 72 (64.9%) and 39 (35.1%) cases, respectively. In propensity score matching, mean number of stent passages for reperfusion was significantly lower in the 4×20 mm SR group than in the 3×20 mm SR group (1.5 ± 0.8 vs. 2.1 ± 1.1; p = 0.004). First-pass reperfusion (FPR) was more highly achieved in the 4×20 mm SR group than in the 3×20 mm SR group (52.6% vs. 42.1%; p = 0.007). In both proximal and distal occlusion cohorts, the 4 mm SR group showed lower mean number of SR passage (p = 0.004 and p =0.003, respectively) and higher FPR rate than the 3 mm SR group (p = 0.003 and p = 0.007, respectively). Conclusion: In MT for M2 occlusion, 4×20 mm SR enables an effective procedure with lesser SR passage for reperfusion and a higher rate of FPR than 3×20 mm SR. result: A total of 111 patients were enrolled, with 4×20 mm SR and 3×20 mm SR applied in 72 (64.9%) and 39 (35.1%) cases, respectively. In propensity score matching, mean number of stent passages for reperfusion was significantly lower in the 4×20 mm SR group than in the 3×20 mm SR group (1.5 ± 0.8 vs. 2.1 ± 1.1; P = 0.004). First pass reperfusion (FPR) was highly achieved in the 4×20 mm SR group than in the 3×20 mm SR group (52.6% vs. 42.1%; P = 0.007). In both proximal and distal occlusion cohorts, the 4 mm SR group showed lower mean number of SR passage (P = 0.004 and P =0.003, respectively) and higher FPR rate than the 3 mm SR group (P = 0.003 and P = 0.007, respectively).
导言:支架回取器(SR)广泛应用于 M2 段闭塞的机械血栓切除术(MT)。然而,M2 闭塞中适合的 SR 尺寸仍不明确。因此,我们旨在比较 4 毫米大小的 SR 与 3 毫米大小的 SR 在 M2 闭塞中的应用。方法:将因 M2 闭塞而使用 SR 进行 MT 的患者分为 4×20 mm SR 组和 3×20 mm SR 组。然后进行 1:1 倾向评分匹配。根据闭塞部位将 M2 节段分为近端和远端节段。然后对每个组群进行亚组分析。结果共有 111 例患者入组,其中 72 例(64.9%)应用了 4×20 mm SR,39 例(35.1%)应用了 3×20 mm SR。在倾向评分匹配中,4×20 毫米 SR 组的再灌注支架平均通过次数明显低于 3×20 毫米 SR 组(1.5 ± 0.8 vs. 2.1 ± 1.1;P = 0.004)。与 3×20 mm SR 组相比,4×20 mm SR 组实现首次再灌注(FPR)的比例更高(52.6% 对 42.1%;P = 0.007)。在近端和远端闭塞队列中,4 毫米 SR 组比 3 毫米 SR 组显示出更低的平均 SR 通过次数(分别为 p = 0.004 和 p =0.003)和更高的 FPR 率(分别为 p = 0.003 和 p =0.007)。结论在 M2 闭塞的 MT 中,与 3×20 mm SR 相比,4×20 mm SR 可使再灌注的 SR 通道更少,FPR 率更高,是一种有效的手术:共有 111 名患者入选,其中 72 例(64.9%)和 39 例(35.1%)分别采用了 4×20 mm SR 和 3×20 mm SR。在倾向评分匹配中,4×20 毫米 SR 组的再灌注支架平均通过次数明显低于 3×20 毫米 SR 组(1.5 ± 0.8 vs. 2.1 ± 1.1;P = 0.004)。与 3×20 mm SR 组相比,4×20 mm SR 组的首次再灌注(FPR)成功率更高(52.6% 对 42.1%;P = 0.007)。在近端和远端闭塞队列中,4 毫米 SR 组比 3 毫米 SR 组显示出更低的平均 SR 通过次数(分别为 P = 0.004 和 P =0.003)和更高的 FPR 率(分别为 P = 0.003 和 P =0.007)。
{"title":"Comparison of 4 mm-sized and 3 mm-sized Stent Retrievers in Mechanical Thrombectomy for M2 Occlusion","authors":"Han Gyul Lee, Ho Jun Yi, Dong-Seong Shin, Bum-Tae Kim","doi":"10.2174/0115672026303196240327053722","DOIUrl":"https://doi.org/10.2174/0115672026303196240327053722","url":null,"abstract":"Introduction: A stent retriever (SR) is widely used in mechanical thrombectomy (MT) for M2 segment occlusion. However, the suitable size of SR in M2 occlusion remains unclear. Therefore, we aimed to compare 4 mm-sized SR with 3 mm-sized SR in M2 occlusion. Methods: Patients who underwent MT with SR for M2 occlusion were dichotomized into 4×20 mm SR and 3×20 mm SR groups. Then, 1:1 propensity score matching was performed. The M2 segment was divided into proximal and distal segments according to the occlusion site. Subgroup analysis was then performed for each cohort. Results: A total of 111 patients were enrolled, with 4×20 mm SR and 3×20 mm SR applied in 72 (64.9%) and 39 (35.1%) cases, respectively. In propensity score matching, mean number of stent passages for reperfusion was significantly lower in the 4×20 mm SR group than in the 3×20 mm SR group (1.5 ± 0.8 vs. 2.1 ± 1.1; p = 0.004). First-pass reperfusion (FPR) was more highly achieved in the 4×20 mm SR group than in the 3×20 mm SR group (52.6% vs. 42.1%; p = 0.007). In both proximal and distal occlusion cohorts, the 4 mm SR group showed lower mean number of SR passage (p = 0.004 and p =0.003, respectively) and higher FPR rate than the 3 mm SR group (p = 0.003 and p = 0.007, respectively). Conclusion: In MT for M2 occlusion, 4×20 mm SR enables an effective procedure with lesser SR passage for reperfusion and a higher rate of FPR than 3×20 mm SR. result: A total of 111 patients were enrolled, with 4×20 mm SR and 3×20 mm SR applied in 72 (64.9%) and 39 (35.1%) cases, respectively. In propensity score matching, mean number of stent passages for reperfusion was significantly lower in the 4×20 mm SR group than in the 3×20 mm SR group (1.5 ± 0.8 vs. 2.1 ± 1.1; P = 0.004). First pass reperfusion (FPR) was highly achieved in the 4×20 mm SR group than in the 3×20 mm SR group (52.6% vs. 42.1%; P = 0.007). In both proximal and distal occlusion cohorts, the 4 mm SR group showed lower mean number of SR passage (P = 0.004 and P =0.003, respectively) and higher FPR rate than the 3 mm SR group (P = 0.003 and P = 0.007, respectively).","PeriodicalId":10879,"journal":{"name":"Current neurovascular research","volume":"47 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140578476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroimaging Marker-CT Perfusion of Early Neurological Deterioration in Patients with Minor Stroke and Large Vessel Occlusion after Intravenous Thrombolysis 静脉溶栓后轻微脑卒中和大血管闭塞患者早期神经功能恶化的神经影像学标志物--CT 灌注
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-04-04 DOI: 10.2174/0115672026306424240319101049
Hongli Zhang, Wanli Bao, Meiyan Yu, Xiang Li, Yongkun Gui, Hongkai Cui, Ping Zhang
Objective: Early Neurological Deterioration (END) is one of the complications in Acute ischemic stroke (AIS) and relates to prognosis. However, the reason why it occurs is still unclear. Our study is to investigate if CT perfusion (CTP) can predict END in patients with Minor Stroke and Large Vessel Occlusion after Intravenous Thrombolysis (IVT). Methods: Patients who underwent IVT with Large Vessel Occlusion were enrolled continuously from January 2021 to August 2023. After evaluating the National Institutes of Health Stroke Scale (NIHSS) score, they were divided into the END group (n=21) and the Non-END group (n=20). Multivariate logistic regression analysis was performed to explore the factors of END. Receiver-operating characteristic (ROC) curve analysis was also used to assess the discriminative ability of CTP in predicting END. Results: A total of 41 patients (mean age, 62.34 ± 10.82 years, 27 male) were finally included in the analysis; 21 patients had END, and 9 patients underwent Endovascular thrombectomy (EVT). Multivariate logistic regression analysis indicated that rCBV (OR=0.081, 95%CI=0.009- 0.721, p = 0.024) and admission-NIHSS (OR=1.990, 95%CI=1.049-3.772, p = 0.035) were significantly associated with END. The area under the curve (AUC) of rCBV and NIHSS to discriminate END were 0.708 and 0.758. We found patients with END had a higher modified Rankin Scale (mRS) in 3 months. Conclusions: The rCBV and NIHSS were associated with post-thrombolysis END and may become reliable markers to predicate END. END might predict a poor 3-month functional outcome.
目的:早期神经功能恶化(END)是急性缺血性卒中(AIS)的并发症之一,与预后有关。然而,END发生的原因仍不清楚。我们的研究旨在探讨 CT 灌注(CTP)能否预测静脉溶栓(IVT)后轻微卒中和大血管闭塞患者的END。研究方法从2021年1月到2023年8月,连续招募接受静脉溶栓治疗并伴有大血管闭塞的患者。评估美国国立卫生研究院卒中量表(NIHSS)评分后,将他们分为END组(21人)和非END组(20人)。为探讨END的影响因素,进行了多变量逻辑回归分析。此外,还采用了接收方操作特征曲线(ROC)分析来评估CTP在预测END方面的鉴别能力。结果共有 41 名患者(平均年龄为 62.34 ± 10.82 岁,27 名男性)被纳入分析,其中 21 名患者患有END,9 名患者接受了血管内血栓切除术(EVT)。多变量逻辑回归分析表明,rCBV(OR=0.081,95%CI=0.009- 0.721,P=0.024)和入院 NIHSS(OR=1.990,95%CI=1.049-3.772,P=0.035)与END显著相关。rCBV和NIHSS判别END的曲线下面积(AUC)分别为0.708和0.758。我们发现END患者3个月后的改良Rankin量表(mRS)更高。结论rCBV和NIHSS与溶栓后END有关,可能成为预测END的可靠指标。END可能预示着3个月后的不良功能预后。
{"title":"Neuroimaging Marker-CT Perfusion of Early Neurological Deterioration in Patients with Minor Stroke and Large Vessel Occlusion after Intravenous Thrombolysis","authors":"Hongli Zhang, Wanli Bao, Meiyan Yu, Xiang Li, Yongkun Gui, Hongkai Cui, Ping Zhang","doi":"10.2174/0115672026306424240319101049","DOIUrl":"https://doi.org/10.2174/0115672026306424240319101049","url":null,"abstract":"Objective: Early Neurological Deterioration (END) is one of the complications in Acute ischemic stroke (AIS) and relates to prognosis. However, the reason why it occurs is still unclear. Our study is to investigate if CT perfusion (CTP) can predict END in patients with Minor Stroke and Large Vessel Occlusion after Intravenous Thrombolysis (IVT). Methods: Patients who underwent IVT with Large Vessel Occlusion were enrolled continuously from January 2021 to August 2023. After evaluating the National Institutes of Health Stroke Scale (NIHSS) score, they were divided into the END group (n=21) and the Non-END group (n=20). Multivariate logistic regression analysis was performed to explore the factors of END. Receiver-operating characteristic (ROC) curve analysis was also used to assess the discriminative ability of CTP in predicting END. Results: A total of 41 patients (mean age, 62.34 ± 10.82 years, 27 male) were finally included in the analysis; 21 patients had END, and 9 patients underwent Endovascular thrombectomy (EVT). Multivariate logistic regression analysis indicated that rCBV (OR=0.081, 95%CI=0.009- 0.721, p = 0.024) and admission-NIHSS (OR=1.990, 95%CI=1.049-3.772, p = 0.035) were significantly associated with END. The area under the curve (AUC) of rCBV and NIHSS to discriminate END were 0.708 and 0.758. We found patients with END had a higher modified Rankin Scale (mRS) in 3 months. Conclusions: The rCBV and NIHSS were associated with post-thrombolysis END and may become reliable markers to predicate END. END might predict a poor 3-month functional outcome.","PeriodicalId":10879,"journal":{"name":"Current neurovascular research","volume":"32 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140602722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Safety and Efficacy of Leo Stents with Coiling or Alone for Anterior cerebral Artery Aneurysms 利奥支架与卷曲或单独治疗大脑前动脉瘤的安全性和有效性
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2023-12-27 DOI: 10.2174/0115672026271147231130111233
Yu Duan, Jun Shen, Xuanfeng Qin, Binbin Xu, Renling Mao, Jian Li, Qinzhu An, Yujun Liao, Fayong Zhang, Gong Chen
Introduction: Treatment of anterior cerebral artery (ACA) aneurysms is still not well established. The Leo stent with blood flow direction is a retrievable stent for intracranial aneurysms, whereas it needs to be studied clearly in patients with ACA aneurysms. Methods: Consecutive patients with ACA aneurysms were retrospectively enrolled in three neurosurgical centers between January 2016 and October 2021. The data on demographics, aneurysm characteristics, symptom resolution, and postoperative course were collected and analyzed. The aneurysm occlusion status was appraised by Raymond-Ray Occlusion Class (RROC). Results: A total of 57 patients with ACA aneurysms were included in our study. Immediate postprocedural angiograms showed that 20 aneurysms (35.1%) were in complete occlusion (RROC 1), 26 aneurysms (45.6%) were in near-complete occlusion (RROC 2), 11 aneurysms (19.3%) were in incomplete occlusion (RROC 3). The angiographic follow-up found that the rate of complete occlusion increased to 57.9%, and near-completion and incomplete occlusion dropped to 29.8% and 12.3%, respectively. The angiographic result of the last follow-up improved significantly (Z=- 2.805, P=0.005). Univariate analysis indicated that distal location of aneurysms (Z=4.538, P=0.033) and ruptured aneurysms (χ2=.6120, P=0.032) were potential risk factors for intra-parent artery narrowing. Furthermore, multivariate logistic regression analysis found that A3 aneurysms (95% CI 1.427~32.744, P=0.016) are the key risk factor for intra-parent artery narrowing. Conclusions: The Leo stent is safe and effective for aneurysms located in ACA circulations. The overall occlusion degree improved during follow-up. A distal, small artery was the risk factor for intra-parent artery narrowing.
导言:大脑前动脉(ACA)动脉瘤的治疗方法尚未得到很好的确定。具有血流方向的利奥支架是一种用于颅内动脉瘤的可回收支架,但在 ACA 动脉瘤患者中的应用仍有待明确研究。方法:2016年1月至2021年10月期间,三家神经外科中心连续回顾性登记了ACA动脉瘤患者。收集并分析了人口统计学、动脉瘤特征、症状缓解和术后病程等数据。动脉瘤闭塞状态由雷蒙德-雷闭塞等级(Raymond-Ray Occlusion Class,RROC)评估。结果本研究共纳入 57 名 ACA 动脉瘤患者。术后即刻血管造影显示,20 个动脉瘤(35.1%)完全闭塞(RROC 1),26 个动脉瘤(45.6%)接近完全闭塞(RROC 2),11 个动脉瘤(19.3%)不完全闭塞(RROC 3)。血管造影随访发现,完全闭塞率增至 57.9%,近完全闭塞率和不完全闭塞率分别降至 29.8%和 12.3%。最后一次随访的血管造影结果明显改善(Z=- 2.805,P=0.005)。单变量分析表明,动脉瘤的远端位置(Z=4.538,P=0.033)和破裂的动脉瘤(χ2=.6120,P=0.032)是父母动脉内狭窄的潜在危险因素。此外,多变量逻辑回归分析发现,A3 动脉瘤(95% CI 1.427~32.744,P=0.016)是父母动脉内狭窄的关键风险因素。结论:利奥支架安全有效:利奥支架对位于 ACA 循环的动脉瘤安全有效。随访期间,总体闭塞程度有所改善。远端小动脉是导致母动脉内狭窄的风险因素。
{"title":"The Safety and Efficacy of Leo Stents with Coiling or Alone for Anterior cerebral Artery Aneurysms","authors":"Yu Duan, Jun Shen, Xuanfeng Qin, Binbin Xu, Renling Mao, Jian Li, Qinzhu An, Yujun Liao, Fayong Zhang, Gong Chen","doi":"10.2174/0115672026271147231130111233","DOIUrl":"https://doi.org/10.2174/0115672026271147231130111233","url":null,"abstract":"Introduction: Treatment of anterior cerebral artery (ACA) aneurysms is still not well established. The Leo stent with blood flow direction is a retrievable stent for intracranial aneurysms, whereas it needs to be studied clearly in patients with ACA aneurysms. Methods: Consecutive patients with ACA aneurysms were retrospectively enrolled in three neurosurgical centers between January 2016 and October 2021. The data on demographics, aneurysm characteristics, symptom resolution, and postoperative course were collected and analyzed. The aneurysm occlusion status was appraised by Raymond-Ray Occlusion Class (RROC). Results: A total of 57 patients with ACA aneurysms were included in our study. Immediate postprocedural angiograms showed that 20 aneurysms (35.1%) were in complete occlusion (RROC 1), 26 aneurysms (45.6%) were in near-complete occlusion (RROC 2), 11 aneurysms (19.3%) were in incomplete occlusion (RROC 3). The angiographic follow-up found that the rate of complete occlusion increased to 57.9%, and near-completion and incomplete occlusion dropped to 29.8% and 12.3%, respectively. The angiographic result of the last follow-up improved significantly (Z=- 2.805, P=0.005). Univariate analysis indicated that distal location of aneurysms (Z=4.538, P=0.033) and ruptured aneurysms (χ2=.6120, P=0.032) were potential risk factors for intra-parent artery narrowing. Furthermore, multivariate logistic regression analysis found that A3 aneurysms (95% CI 1.427~32.744, P=0.016) are the key risk factor for intra-parent artery narrowing. Conclusions: The Leo stent is safe and effective for aneurysms located in ACA circulations. The overall occlusion degree improved during follow-up. A distal, small artery was the risk factor for intra-parent artery narrowing.","PeriodicalId":10879,"journal":{"name":"Current neurovascular research","volume":"30 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139055594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: The Role of White Blood Cell Count to Mean Platelet Volume Ratio 预测接受血管内血栓切除术的急性缺血性脑卒中患者的再通术失败率:白细胞计数与平均血小板体积比的作用
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2023-12-23 DOI: 10.2174/0115672026288143231212051101
Wantong Yu, Milan Jia, Wenting Guo, Jiali Xu, Changhong Ren, Sijie li, Wenbo Zhao, Jian Chen, Jiangang Duan, Qingfeng Ma, Haiqing Song, Xunming Ji
Background:: Approximately half of AIS patients have an unfavorable outcome even after complete reperfusion. White blood cell (WBC) count to mean platelet volume (MPV) ratio (WMR) may be a promising predictive factor for futile recanalization. This study aimed to determine the predictive value of WMR in identifying individuals at higher risk of futile recanalization. Methods:: In this retrospective cohort study, 296 patients who achieved complete reperfusion after endovascular treatment (EVT) were included in the analysis. WBC count and MPV were collected at admission. Multivariable logistic regression was used to examine the independent association of the WMR with functional outcomes at three months. Net reclassification improvement (NRI) and integrated discrimination improvement (IDI) analyses were used to compare the accuracy of WMR for predicting futile recanalization. Results:: The adjusted odds ratios for the fourth quartile of WMR were 3.142 (95% CI 1.405- 7.027, P = 0.005) for unfavorable outcomes at 3 months in comparison with the first quartile. The inclusion of WMR in the traditional model enabled a more accurate prediction of unfavorable outcomes (NRI 0.250, P = 0.031; IDI 0.022, P = 0.017). Conclusion:: Elevated WMR at admission was independently associated with futile recanalization among AIS patients who received EVT and might be useful in identifying futile recanalization.
背景约有一半的 AIS 患者即使在完全再灌注后仍会出现不良预后。白细胞(WBC)计数与平均血小板体积(MPV)比值(WMR)可能是预测无效再通畅的一个有希望的因素。本研究旨在确定 WMR 在识别无效再通风险较高的患者方面的预测价值。方法在这项回顾性队列研究中,分析对象包括 296 名在血管内治疗 (EVT) 后实现完全再灌注的患者。入院时收集了白细胞计数和MPV。研究采用多变量逻辑回归来检验 WMR 与三个月后功能预后的独立关联。净再分类改进(NRI)和综合辨别改进(IDI)分析用于比较 WMR 预测无效再通畅的准确性。结果与第一四分位数相比,WMR 第四四分位数在 3 个月后出现不利结果的调整后几率为 3.142 (95% CI 1.405- 7.027, P = 0.005)。将 WMR 纳入传统模型可更准确地预测不利预后(NRI 0.250,P = 0.031;IDI 0.022,P = 0.017)。结论在接受EVT的AIS患者中,入院时WMR升高与无效再通有独立关联,可能有助于识别无效再通。
{"title":"Predicting Futile Recanalization in Acute Ischemic Stroke Patients Undergoing Endovascular Thrombectomy: The Role of White Blood Cell Count to Mean Platelet Volume Ratio","authors":"Wantong Yu, Milan Jia, Wenting Guo, Jiali Xu, Changhong Ren, Sijie li, Wenbo Zhao, Jian Chen, Jiangang Duan, Qingfeng Ma, Haiqing Song, Xunming Ji","doi":"10.2174/0115672026288143231212051101","DOIUrl":"https://doi.org/10.2174/0115672026288143231212051101","url":null,"abstract":"Background:: Approximately half of AIS patients have an unfavorable outcome even after complete reperfusion. White blood cell (WBC) count to mean platelet volume (MPV) ratio (WMR) may be a promising predictive factor for futile recanalization. This study aimed to determine the predictive value of WMR in identifying individuals at higher risk of futile recanalization. Methods:: In this retrospective cohort study, 296 patients who achieved complete reperfusion after endovascular treatment (EVT) were included in the analysis. WBC count and MPV were collected at admission. Multivariable logistic regression was used to examine the independent association of the WMR with functional outcomes at three months. Net reclassification improvement (NRI) and integrated discrimination improvement (IDI) analyses were used to compare the accuracy of WMR for predicting futile recanalization. Results:: The adjusted odds ratios for the fourth quartile of WMR were 3.142 (95% CI 1.405- 7.027, P = 0.005) for unfavorable outcomes at 3 months in comparison with the first quartile. The inclusion of WMR in the traditional model enabled a more accurate prediction of unfavorable outcomes (NRI 0.250, P = 0.031; IDI 0.022, P = 0.017). Conclusion:: Elevated WMR at admission was independently associated with futile recanalization among AIS patients who received EVT and might be useful in identifying futile recanalization.","PeriodicalId":10879,"journal":{"name":"Current neurovascular research","volume":"15 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139030354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Remote Ischemic Postconditioning on Quality of Life and Clinical Events after an Ischemic Stroke 缺血性脑卒中后远程缺血后处理对生活质量和临床事件的影响
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2023-12-15 DOI: 10.2174/0115672026275008231120063757
Thijs P. Kerstens, Thijs R.J. Landman, Yvonne Schoon, Frederick J.A. Meijer, Michiel C. Warlé, Frank-Erik de Leeuw, Dick H.J. Thijssen
Objectives: Repeated remote ischemic postconditioning (rIPostC) may be an easily applicable treatment following ischemic stroke to improve quality of life (QoL) and clinical outcomes. rIPostC consists of repeated, brief periods of limb ischemia (through inflation of a blood pressure cuff), followed by reperfusion. This study investigated the 1-year follow-up of rIPostC on QoL and clinical events. Methods: As part of a randomized controlled trial, adult patients with an ischemic stroke within 24 hours after onset of symptoms were randomized to repeated rIPostC or sham-conditioning. rIPostC was applied twice daily during hospitalization (maximum of 4 days). QoL and patientreported outcome measures (PROMs) were assessed at 12-week and 1-year follow-ups. Additionally, we explored the effect of repeated rIPostC on clinical events (recurrent cerebrovascular events, hospitalization, and mortality). Results: The trial was preliminarily stopped due to limitations in recruitment after the inclusion of 88 patients (rIPostC: 40; sham-conditioning: 48) (70 years, 68% male). Questionnaires were returned by 69 (78%) and 63 (72%) participants after 12 weeks and 1 year, respectively. The median difference of the stroke-specific QoL between rIPostC and sham-conditioning was 0.05 (p =0.986) and -0.16 (p =0.654) after 12 weeks and 1-year, respectively. No significant effect of rIPostC on the different domains of PROMs was detected. We observed no between-group differences in recurrent cerebrovascular events, hospitalization, or all-cause mortality (Hazard Ratios p >0.05). Conclusion: In this exploratory analysis, we observed no significant difference between repeated rIPostC and usual care on QoL and clinical outcomes at 12 weeks and 1 year in patients with an ischemic stroke. other: -
目的:重复远端缺血后调节(rIPostC)是缺血性脑卒中后的一种简便易行的治疗方法,可改善患者的生活质量(QoL)和临床预后。本研究调查了 rIPostC 对 QoL 和临床事件的 1 年随访情况。研究方法作为随机对照试验的一部分,发病后 24 小时内的缺血性中风成年患者被随机分配到重复 rIPostC 或假调节。在 12 周和 1 年的随访中评估了 QoL 和患者报告的结果指标 (PROM)。此外,我们还探讨了重复使用 rIPostC 对临床事件(复发性脑血管事件、住院和死亡率)的影响。结果:该试验在纳入 88 名患者(rIPostC:40 人;假调节:48 人)(70 岁,68% 为男性)后,因招募人数有限而初步停止。分别有 69 人(78%)和 63 人(72%)在 12 周和 1 年后返回了问卷。12 周后和 1 年后,rIPostC 和假调节疗法对中风特异性 QoL 的中位数差异分别为 0.05(p =0.986)和-0.16(p =0.654)。没有发现 rIPostC 对 PROMs 的不同领域有明显影响。在复发性脑血管事件、住院或全因死亡率方面,我们没有观察到组间差异(危险比 p >0.05)。结论:在这项探索性分析中,我们观察到重复 rIPostC 与常规护理在缺血性中风患者 12 周和 1 年的 QoL 和临床结果上没有显著差异。
{"title":"The Effect of Remote Ischemic Postconditioning on Quality of Life and Clinical Events after an Ischemic Stroke","authors":"Thijs P. Kerstens, Thijs R.J. Landman, Yvonne Schoon, Frederick J.A. Meijer, Michiel C. Warlé, Frank-Erik de Leeuw, Dick H.J. Thijssen","doi":"10.2174/0115672026275008231120063757","DOIUrl":"https://doi.org/10.2174/0115672026275008231120063757","url":null,"abstract":"Objectives: Repeated remote ischemic postconditioning (rIPostC) may be an easily applicable treatment following ischemic stroke to improve quality of life (QoL) and clinical outcomes. rIPostC consists of repeated, brief periods of limb ischemia (through inflation of a blood pressure cuff), followed by reperfusion. This study investigated the 1-year follow-up of rIPostC on QoL and clinical events. Methods: As part of a randomized controlled trial, adult patients with an ischemic stroke within 24 hours after onset of symptoms were randomized to repeated rIPostC or sham-conditioning. rIPostC was applied twice daily during hospitalization (maximum of 4 days). QoL and patientreported outcome measures (PROMs) were assessed at 12-week and 1-year follow-ups. Additionally, we explored the effect of repeated rIPostC on clinical events (recurrent cerebrovascular events, hospitalization, and mortality). Results: The trial was preliminarily stopped due to limitations in recruitment after the inclusion of 88 patients (rIPostC: 40; sham-conditioning: 48) (70 years, 68% male). Questionnaires were returned by 69 (78%) and 63 (72%) participants after 12 weeks and 1 year, respectively. The median difference of the stroke-specific QoL between rIPostC and sham-conditioning was 0.05 (p =0.986) and -0.16 (p =0.654) after 12 weeks and 1-year, respectively. No significant effect of rIPostC on the different domains of PROMs was detected. We observed no between-group differences in recurrent cerebrovascular events, hospitalization, or all-cause mortality (Hazard Ratios p >0.05). Conclusion: In this exploratory analysis, we observed no significant difference between repeated rIPostC and usual care on QoL and clinical outcomes at 12 weeks and 1 year in patients with an ischemic stroke. other: -","PeriodicalId":10879,"journal":{"name":"Current neurovascular research","volume":"27 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138683544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association between Serum Total Bilirubin and Severe Headaches or Migraine in American Adults 美国成年人血清总胆红素与严重头痛或偏头痛之间的关系
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2023-12-15 DOI: 10.2174/0115672026284009231120065521
Yuting He, Hao Huang, Lingao Dai, Xiaoping Wang
Background: Studies about the association between bilirubin and migraine were few. Therefore, the purpose of this study was to investigate the association between serum total bilirubin and the prevalence of severe headaches or migraine. Methods: A multivariable logistic regression was used to assess the association between serum total bilirubin concentration and severe headaches or migraine. We also performed stratified analyses, interaction analyses and multiple interpolations in the sensitivity analysis. Results: This cross-sectional study included 12,552 adults from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2004. The overall incidence of migraine was 19.99% (2,509/12,552). With every 1 mg/dl increase in bilirubin, the prevalence of migraine decreased by 23% (95% CI: 0.64, 0.93) after adjustment of all related covariates. Similarly, the risk of migraine was reduced by 17% (95% CI: 0.72, 0.97) in the Q4 group (the fourth quartile, highest serum total bilirubin level) compared with the Q1 group (the lowest level). Furthermore, interaction effects by age groups were significant in this relationship (P for interaction = 0.0004). In the Q4 group compared with Q1, inverse associations were observed in those aged ≥40 years (OR: 0.71,95% CI: 0.59, 0.85) in the stratified analysis. Conclusion: These findings support an association between serum total bilirubin and severe headaches or migraine, revealing an inverse association between serum total bilirubin quartiles and severe headaches or migraine in American adults. Age could play an important role in this association.
背景:有关胆红素与偏头痛之间关系的研究很少。因此,本研究旨在调查血清总胆红素与严重头痛或偏头痛发病率之间的关系。研究方法采用多变量逻辑回归评估血清总胆红素浓度与严重头痛或偏头痛之间的关系。我们还在敏感性分析中进行了分层分析、交互作用分析和多重插值分析。研究结果这项横断面研究纳入了 1999 年至 2004 年美国国家健康与营养调查(NHANES)中的 12,552 名成年人。偏头痛的总发病率为 19.99%(2,509/12,552)。在对所有相关协变量进行调整后,胆红素每增加 1 毫克/分升,偏头痛的发病率就会降低 23% (95% CI: 0.64, 0.93)。同样,Q4 组(第四四分位数,血清总胆红素水平最高)与 Q1 组(最低水平)相比,偏头痛风险降低了 17% (95% CI: 0.72, 0.97)。此外,各年龄组的交互效应在这一关系中也很显著(交互效应的 P = 0.0004)。在分层分析中,Q4 组与 Q1 组相比,在年龄≥40 岁的人群中观察到逆相关性(OR:0.71,95% CI:0.59, 0.85)。结论这些研究结果支持血清总胆红素与严重头痛或偏头痛之间的关系,揭示了美国成年人血清总胆红素四分位数与严重头痛或偏头痛之间的反向关系。年龄可能在这种关联中扮演重要角色。
{"title":"The Association between Serum Total Bilirubin and Severe Headaches or Migraine in American Adults","authors":"Yuting He, Hao Huang, Lingao Dai, Xiaoping Wang","doi":"10.2174/0115672026284009231120065521","DOIUrl":"https://doi.org/10.2174/0115672026284009231120065521","url":null,"abstract":"Background: Studies about the association between bilirubin and migraine were few. Therefore, the purpose of this study was to investigate the association between serum total bilirubin and the prevalence of severe headaches or migraine. Methods: A multivariable logistic regression was used to assess the association between serum total bilirubin concentration and severe headaches or migraine. We also performed stratified analyses, interaction analyses and multiple interpolations in the sensitivity analysis. Results: This cross-sectional study included 12,552 adults from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2004. The overall incidence of migraine was 19.99% (2,509/12,552). With every 1 mg/dl increase in bilirubin, the prevalence of migraine decreased by 23% (95% CI: 0.64, 0.93) after adjustment of all related covariates. Similarly, the risk of migraine was reduced by 17% (95% CI: 0.72, 0.97) in the Q4 group (the fourth quartile, highest serum total bilirubin level) compared with the Q1 group (the lowest level). Furthermore, interaction effects by age groups were significant in this relationship (P for interaction = 0.0004). In the Q4 group compared with Q1, inverse associations were observed in those aged ≥40 years (OR: 0.71,95% CI: 0.59, 0.85) in the stratified analysis. Conclusion: These findings support an association between serum total bilirubin and severe headaches or migraine, revealing an inverse association between serum total bilirubin quartiles and severe headaches or migraine in American adults. Age could play an important role in this association.","PeriodicalId":10879,"journal":{"name":"Current neurovascular research","volume":"27 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138683537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between Carotid Blood Flow Velocity and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease in Patients with Recent Small Subcortical Infarcts 近期皮层下小梗死患者颈动脉血流速度与磁共振成像中脑小血管疾病总负担之间的相关性
IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2023-12-15 DOI: 10.2174/0115672026285373231120054627
Yi-Jun lv, Min Zhang, Wen-Wei Yun, Qing-Xiu Zhang, Jing-Wei LI
Background: The common and internal carotid arteries are the upstream vessels of the small cerebral vessels. The relationship between hemodynamic changes in the significant cervical vessels and cerebral small vessel disease (CSVD) remains uncertain. This research sought to analyze the correlation between carotid blood flow velocity and the total magnetic resonance imaging (MRI) burden of CSVD in patients with recent small subcortical infarcts (RSSIs). background: The common and internal carotid arteries are the upstream vessels of the small cerebral vessels. The relationship between hemodynamic changes in the significant cervical vessels and cerebral small vessel disease (CSVD) remains uncertain. Methods: Data were gathered from individuals diagnosed with RSSIs admitted to Changzhou Second People's Hospital between January 2022 and June 2023. Brain MRI was performed on every patient to determine the overall MRI burden of CSVD, along with carotid duplex ultrasound to evaluate carotid blood flow velocity and pulsatility index (PI) of the common carotid (CCA) and internal carotid (ICA) arteries. The association between carotid blood flow velocity and the total MRI load of CSVD was examined using univariate and multivariate analyses. objective: This research sought to analyze the correlation between carotid blood flow velocity and the total magnetic resonance imaging (MRI) burden of CSVD in patients with recent small subcortical infarcts(RSSIs). Results: For our investigation, 272 individuals with RSSIs were screened. 82 individuals had a moderate to severe load of CSVD, while 190 participants showed a mild burden. Patients with moderate to severe burden of CSVD had lower end-diastolic velocity (EDV) and higher PI in CCA and ICA than those with mild load (P < 0.001). After adjusting for variables like age, hypertension, systolic blood pressure, and blood homocysteine levels, multivariate logistic regression analysis showed that EDV in CCA (OR, 0.894; P = 0.011), PI in CCA (OR, 5.869; P = 0.017), EDV in ICA (OR, 0.909; P = 0.008), and PI in ICA (OR, 5.324; P = 0.041) were independently related to moderate to severe CSVD burden. Spearman correlation analysis showed that EDV in CCA and ICA was negatively related to the total MRI load of CSVD in patients with RSSIs (P < 0.001). PI in CCA and ICA was positively associated with the whole MRI load of CSVD (P < 0.001). Conclusion: Low carotid blood flow velocity and high carotid pulsatility index are independently associated with moderate to severe burden of CSVD. other: none
背景:颈总动脉和颈内动脉是大脑小血管的上游血管。颈部重要血管的血流动力学变化与脑小血管疾病(CSVD)之间的关系仍不确定。本研究试图分析近期皮层下小梗死(RSSI)患者颈动脉血流速度与 CSVD 总磁共振成像(MRI)负荷之间的相关性:颈总动脉和颈内动脉是小脑血管的上游血管。显性颈内血管的血流动力学变化与大脑小血管疾病(CSVD)之间的关系仍不确定。研究方法收集2022年1月至2023年6月期间常州市第二人民医院收治的RSSI患者的数据。对每位患者进行脑磁共振成像检查,以确定CSVD的总体磁共振成像负荷,同时进行颈动脉双相超声检查,以评估颈总动脉(CCA)和颈内动脉(ICA)的颈动脉血流速度和搏动指数(PI)。通过单变量和多变量分析,研究了颈动脉血流速度与 CSVD MRI 总负荷之间的关联:本研究旨在分析近期皮层下小梗死(RSSI)患者颈动脉血流速度与 CSVD 的磁共振成像(MRI)总负荷之间的相关性。研究结果我们共筛查了 272 名 RSSI 患者。其中 82 人有中度至重度 CSVD 负荷,190 人有轻度 CSVD 负荷。与轻度CSVD患者相比,中重度CSVD患者的舒张末期速度(EDV)较低,CCA和ICA的PI较高(P< 0.001)。在对年龄、高血压、收缩压和血同型半胱氨酸水平等变量进行调整后,多变量逻辑回归分析表明,CCA 的 EDV(OR,0.894;P = 0.011)、CCA 的 PI(OR,5.869;P = 0.017)、ICA 的 EDV(OR,0.909;P = 0.008)和 ICA 的 PI(OR,5.324;P = 0.041)与中度至重度 CSVD 负荷独立相关。斯皮尔曼相关分析表明,CCA和ICA的EDV与RSSI患者CSVD的MRI总负荷呈负相关(P < 0.001)。CCA和ICA的PI与CSVD的MRI总负荷呈正相关(P <0.001)。结论低颈动脉血流速度和高颈动脉搏动指数与中度至重度 CSVD 负荷独立相关。 其他:无
{"title":"Correlation between Carotid Blood Flow Velocity and Total Magnetic Resonance Imaging Burden of Cerebral Small Vessel Disease in Patients with Recent Small Subcortical Infarcts","authors":"Yi-Jun lv, Min Zhang, Wen-Wei Yun, Qing-Xiu Zhang, Jing-Wei LI","doi":"10.2174/0115672026285373231120054627","DOIUrl":"https://doi.org/10.2174/0115672026285373231120054627","url":null,"abstract":"Background: The common and internal carotid arteries are the upstream vessels of the small cerebral vessels. The relationship between hemodynamic changes in the significant cervical vessels and cerebral small vessel disease (CSVD) remains uncertain. This research sought to analyze the correlation between carotid blood flow velocity and the total magnetic resonance imaging (MRI) burden of CSVD in patients with recent small subcortical infarcts (RSSIs). background: The common and internal carotid arteries are the upstream vessels of the small cerebral vessels. The relationship between hemodynamic changes in the significant cervical vessels and cerebral small vessel disease (CSVD) remains uncertain. Methods: Data were gathered from individuals diagnosed with RSSIs admitted to Changzhou Second People's Hospital between January 2022 and June 2023. Brain MRI was performed on every patient to determine the overall MRI burden of CSVD, along with carotid duplex ultrasound to evaluate carotid blood flow velocity and pulsatility index (PI) of the common carotid (CCA) and internal carotid (ICA) arteries. The association between carotid blood flow velocity and the total MRI load of CSVD was examined using univariate and multivariate analyses. objective: This research sought to analyze the correlation between carotid blood flow velocity and the total magnetic resonance imaging (MRI) burden of CSVD in patients with recent small subcortical infarcts(RSSIs). Results: For our investigation, 272 individuals with RSSIs were screened. 82 individuals had a moderate to severe load of CSVD, while 190 participants showed a mild burden. Patients with moderate to severe burden of CSVD had lower end-diastolic velocity (EDV) and higher PI in CCA and ICA than those with mild load (P &lt; 0.001). After adjusting for variables like age, hypertension, systolic blood pressure, and blood homocysteine levels, multivariate logistic regression analysis showed that EDV in CCA (OR, 0.894; P = 0.011), PI in CCA (OR, 5.869; P = 0.017), EDV in ICA (OR, 0.909; P = 0.008), and PI in ICA (OR, 5.324; P = 0.041) were independently related to moderate to severe CSVD burden. Spearman correlation analysis showed that EDV in CCA and ICA was negatively related to the total MRI load of CSVD in patients with RSSIs (P &lt; 0.001). PI in CCA and ICA was positively associated with the whole MRI load of CSVD (P &lt; 0.001). Conclusion: Low carotid blood flow velocity and high carotid pulsatility index are independently associated with moderate to severe burden of CSVD. other: none","PeriodicalId":10879,"journal":{"name":"Current neurovascular research","volume":"24 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138683540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current neurovascular research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1